According to recent studies, the pathogenesis of immune thrombocytopenia is related to abnormal tryptophan metabolism mediated by indoleamine 2,3-dioxygenase (IDO), which decreases IDO activity and increases tryptophan concentration [54]. This evidence concerns the gene IDO1 and autoimmune thrombocytopenic purpura.